Clinical Trial Update: Use of Spectral OCT in Combination Therapy

View source ↗

Summary

This entry reports the completion of a clinical trial evaluating the use of Spectral OCT in combination therapy for choroidal neovascularization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neovascularization

Snippet

Sponsor: Barnes Retina Institute | Conditions: Choroidal Neovascularization | Status: COMPLETED